{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:12:21Z","timestamp":1792541541750,"version":"4.5.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum W\u00fcrzburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00134-026-08491-6","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T10:39:15Z","timestamp":1780915155000},"page":"1290-1305","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Patient blood management in general intensive care patients"],"prefix":"10.1007","volume":"52","author":[{"given":"Patrick","family":"Meybohm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Fries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigismond","family":"Lasocki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander P. J.","family":"Vlaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zacharowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0817-3371","authenticated-orcid":false,"given":"Suma","family":"Choorapoikayil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"issue":"10","key":"8491_CR1","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1164\/rccm.201110-1915CI","volume":"185","author":"SJ Hayden","year":"2012","unstructured":"Hayden SJ, Albert TJ, Watkins TR, Swenson ER (2012) Anemia in critical illness: insights into etiology, consequences, and management. Am J Respir Crit Care Med 185(10):1049\u20131057. https:\/\/doi.org\/10.1164\/rccm.201110-1915CI","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"8491_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40560-023-00672-5","volume":"11","author":"T Iba","year":"2023","unstructured":"Iba T, Helms J, Connors JM, Levy JH (2023) The pathophysiology, diagnosis, and management of sepsis-associated disseminated intravascular coagulation. J Intensive Care 11(1):24. https:\/\/doi.org\/10.1186\/s40560-023-00672-5","journal-title":"J Intensive Care"},{"issue":"9","key":"8491_CR3","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1056\/NEJMra1208626","volume":"370","author":"BJ Hunt","year":"2014","unstructured":"Hunt BJ (2014) Bleeding and coagulopathies in critical care. N Engl J Med 370(9):847\u2013859. https:\/\/doi.org\/10.1056\/NEJMra1208626","journal-title":"N Engl J Med"},{"issue":"22","key":"8491_CR4","doi-asserted-by":"publisher","first-page":"5369","DOI":"10.3390\/jcm10225369","volume":"10","author":"FS Neuenfeldt","year":"2021","unstructured":"Neuenfeldt FS, Weigand MA, Fischer D (2021) Coagulopathies in intensive care medicine: balancing act between thrombosis and bleeding. J Clin Med 10(22):5369. https:\/\/doi.org\/10.3390\/jcm10225369","journal-title":"J Clin Med"},{"issue":"1","key":"8491_CR5","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/trf.12791","volume":"55","author":"RM Kaufman","year":"2015","unstructured":"Kaufman RM, Assmann SF, Triulzi DJ, Strauss RG, Ness P, Granger S et al (2015) Transfusion-related adverse events in the Platelet Dose study. Transfusion (Paris) 55(1):144\u2013153. https:\/\/doi.org\/10.1111\/trf.12791","journal-title":"Transfusion (Paris)"},{"issue":"Suppl 1","key":"8491_CR6","doi-asserted-by":"publisher","first-page":"65S","DOI":"10.1111\/j.1537-2995.2012.03663.x","volume":"52 Suppl 1","author":"S Pandey","year":"2012","unstructured":"Pandey S, Vyas GN (2012) Adverse effects of plasma transfusion. Transfusion (Paris) 52 Suppl 1(Suppl 1):65S\u201379S. https:\/\/doi.org\/10.1111\/j.1537-2995.2012.03663.x","journal-title":"Transfusion (Paris)"},{"issue":"5","key":"8491_CR7","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1159\/000151350","volume":"35","author":"V Kiefel","year":"2008","unstructured":"Kiefel V (2008) Reactions induced by platelet transfusions. Transfus Med Hemother Off Organ Dtsch Ges Transfusionsmedizin Immunhamatologie 35(5):354\u2013358. https:\/\/doi.org\/10.1159\/000151350","journal-title":"Transfus Med Hemother Off Organ Dtsch Ges Transfusionsmedizin Immunhamatologie"},{"issue":"2","key":"8491_CR8","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1213\/ANE.0000000000006917","volume":"140","author":"S Lasocki","year":"2025","unstructured":"Lasocki S, Belbachir A, Mertes PM, Le Pelley E, Bosch L, Bezault C et al (2025) Changes in practices after implementation of a patient blood management program in french surgical departments: the National Multicenter Observational PERIOPES Study. Anesth Analg 140(2):453\u2013464. https:\/\/doi.org\/10.1213\/ANE.0000000000006917","journal-title":"Anesth Analg"},{"issue":"5","key":"8491_CR9","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1097\/SLA.0000000000003095","volume":"269","author":"FC Althoff","year":"2019","unstructured":"Althoff FC, Neb H, Herrmann E, Trentino KM, Vernich L, F\u00fcllenbach C et al (2019) Multimodal patient blood management program based on a three-pillar strategy: a systematic review and meta-analysis. Ann Surg 269(5):794\u2013804. https:\/\/doi.org\/10.1097\/SLA.0000000000003095","journal-title":"Ann Surg"},{"issue":"1","key":"8491_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.bpa.2013.01.001","volume":"27","author":"A Shander","year":"2013","unstructured":"Shander A, Hofmann A, Isbister J, Van Aken H (2013) Patient blood management\u2014the new frontier. Best Pract Res Clin Anaesthesiol 27(1):5\u201310. https:\/\/doi.org\/10.1016\/j.bpa.2013.01.001","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"8491_CR11","unstructured":"WHO (2025) Guidance on implementing patient blood management to improve global blood health status [Internet]. World Health Organization [cited 2025 Oct 27]. Available from: https:\/\/www.who.int\/publications\/b\/76782"},{"issue":"3","key":"8491_CR12","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.bja.2023.05.006","volume":"131","author":"P Meybohm","year":"2023","unstructured":"Meybohm P, Schmitt E, Choorapoikayil S, Hof L, Old O, M\u00fcller MM et al (2023) German Patient Blood Management Network: effectiveness and safety analysis in 1.2 million patients. Br J Anaesth 131(3):472\u2013481. https:\/\/doi.org\/10.1016\/j.bja.2023.05.006","journal-title":"Br J Anaesth"},{"issue":"12","key":"8491_CR13","doi-asserted-by":"publisher","first-page":"e2041","DOI":"10.1016\/S2214-109X(25)00320-1","volume":"13","author":"S Choorapoikayil","year":"2025","unstructured":"Choorapoikayil S, Baron DM, Spahn DR, Lasocki S, Boryshchuk D, Yeghiazaryan L et al (2025) The aetiology and prevalence of preoperative anaemia in patients undergoing major surgery (ALICE): an international, prospective, observational cohort study. Lancet Glob Health 13(12):e2041\u2013e2050. https:\/\/doi.org\/10.1016\/S2214-109X(25)00320-1","journal-title":"Lancet Glob Health"},{"issue":"9","key":"8491_CR14","doi-asserted-by":"publisher","first-page":"e713","DOI":"10.1016\/S2352-3026(23)00160-6","volume":"10","author":"GBD 2021 Anaemia Collaborators","year":"2021","unstructured":"GBD 2021 Anaemia Collaborators (2021) Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990\u20132021: findings from the Global Burden of Disease Study 2021. Lancet Haematol 10(9):e713\u2013e734. https:\/\/doi.org\/10.1016\/S2352-3026(23)00160-6","journal-title":"Lancet Haematol"},{"key":"8491_CR15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jcrc.2018.11.005","volume":"49","author":"A Shah","year":"2019","unstructured":"Shah A, Fisher SA, Wong H, Roy NB, McKechnie S, Doree C et al (2019) Safety and efficacy of iron therapy on reducing red blood cell transfusion requirements and treating anaemia in critically ill adults: a systematic review with meta-analysis and trial sequential analysis. J Crit Care 49:162\u2013171. https:\/\/doi.org\/10.1016\/j.jcrc.2018.11.005","journal-title":"J Crit Care"},{"issue":"1","key":"8491_CR16","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s13054-016-1486-z","volume":"20","author":"A Shah","year":"2016","unstructured":"Shah A, Roy NB, McKechnie S, Doree C, Fisher SA, Stanworth SJ (2016) Iron supplementation to treat anaemia in adult critical care patients: a systematic review and meta-analysis. Crit Care Lond Engl 20(1):306. https:\/\/doi.org\/10.1186\/s13054-016-1486-z","journal-title":"Crit Care Lond Engl"},{"issue":"2","key":"8491_CR17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.tmrv.2021.12.002","volume":"36","author":"LJ Geneen","year":"2022","unstructured":"Geneen LJ, Kimber C, Doree C, Stanworth S, Shah A (2022) Efficacy and safety of intravenous iron therapy for treating anaemia in critically ill adults: a rapid systematic review with meta-analysis. Transfus Med Rev 36(2):97\u2013106. https:\/\/doi.org\/10.1016\/j.tmrv.2021.12.002","journal-title":"Transfus Med Rev"},{"key":"8491_CR18","doi-asserted-by":"publisher","first-page":"111743","DOI":"10.1016\/j.jclinane.2025.111743","volume":"102","author":"H Ehrentraut","year":"2025","unstructured":"Ehrentraut H, Massoth G, Delis A, Thewes B, Hoch J, Majchrzak M et al (2025) Implications of packed red bloods cells production and transfer on post transfusion hemoglobin increase. J Clin Anesth 102:111743. https:\/\/doi.org\/10.1016\/j.jclinane.2025.111743","journal-title":"J Clin Anesth"},{"issue":"13","key":"8491_CR19","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1182\/blood.2019000773","volume":"134","author":"NH Roubinian","year":"2019","unstructured":"Roubinian NH, Plimier C, Woo JP, Lee C, Bruhn R, Liu VX et al (2019) Effect of donor, component, and recipient characteristics on hemoglobin increments following red blood cell transfusion. Blood 134(13):1003\u20131013. https:\/\/doi.org\/10.1182\/blood.2019000773","journal-title":"Blood"},{"issue":"2","key":"8491_CR20","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s12028-008-9113-8","volume":"9","author":"AM Naidech","year":"2008","unstructured":"Naidech AM, Kahn MJ, Soong W, Green D, Batjer HH, Bleck TP (2008) Packed red blood cell transfusion causes greater hemoglobin rise at a lower starting hemoglobin in patients with subarachnoid hemorrhage. Neurocrit Care 9(2):198\u2013203. https:\/\/doi.org\/10.1007\/s12028-008-9113-8","journal-title":"Neurocrit Care"},{"issue":"11","key":"8491_CR21","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1007\/s00134-016-4465-6","volume":"42","author":"E Litton","year":"2016","unstructured":"IRONMAN Investigators, Litton E, Baker S, Erber WN, Farmer S, Ferrier J et al (2016) Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial: a randomized trial of IV iron in critical illness. Intensive Care Med 42(11):1715\u20131722. https:\/\/doi.org\/10.1007\/s00134-016-4465-6","journal-title":"Intensive Care Med"},{"issue":"1","key":"8491_CR22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","volume":"39","author":"M Valko","year":"2007","unstructured":"Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39(1):44\u201384. https:\/\/doi.org\/10.1016\/j.biocel.2006.07.001","journal-title":"Int J Biochem Cell Biol"},{"issue":"31","key":"8491_CR23","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.2174\/138161211798072463","volume":"17","author":"K Jomova","year":"2011","unstructured":"Jomova K, Valko M (2011) Importance of iron chelation in free radical-induced oxidative stress and human disease. Curr Pharm Des 17(31):3460\u20133473. https:\/\/doi.org\/10.2174\/138161211798072463","journal-title":"Curr Pharm Des"},{"issue":"11","key":"8491_CR24","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.2215\/CJN.02840314","volume":"9","author":"DE Leaf","year":"2014","unstructured":"Leaf DE, Rajapurkar M, Lele SS, Mukhopadhyay B, Waikar SS (2014) Plasma catalytic iron, AKI, and death among critically ill patients. Clin J Am Soc Nephrol CJASN 9(11):1849\u20131856. https:\/\/doi.org\/10.2215\/CJN.02840314","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"5","key":"8491_CR25","doi-asserted-by":"publisher","first-page":"F871","DOI":"10.1152\/ajprenal.00388.2016","volume":"311","author":"DE Leaf","year":"2016","unstructured":"Leaf DE, Swinkels DW (2016) Catalytic iron and acute kidney injury. Am J Physiol Renal Physiol 311(5):F871\u2013F876. https:\/\/doi.org\/10.1152\/ajprenal.00388.2016","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"8491_CR26","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1186\/s13054-023-04759-1","volume":"27","author":"C Grange","year":"2023","unstructured":"Grange C, Lux F, Brichart T, David L, Couturier A, Leaf DE et al (2023) Iron as an emerging therapeutic target in critically ill patients. Crit Care 27(1):475. https:\/\/doi.org\/10.1186\/s13054-023-04759-1","journal-title":"Crit Care"},{"issue":"3","key":"8491_CR27","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/CCM.0000000000001420","volume":"44","author":"S Lasocki","year":"2016","unstructured":"Lasocki S, Piednoir P, Couffignal C, Rineau E, Dufour G, Lefebvre T et al (2016) Does IV iron induce plasma oxidative stress in critically ill patients? A comparison with healthy volunteers. Crit Care Med 44(3):521\u2013530. https:\/\/doi.org\/10.1097\/CCM.0000000000001420","journal-title":"Crit Care Med"},{"issue":"6","key":"8491_CR28","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1159\/000107928","volume":"27","author":"P Malindretos","year":"2007","unstructured":"Malindretos P, Sarafidis PA, Rudenco I, Raptis V, Makedou K, Makedou A et al (2007) Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran. Am J Nephrol 27(6):572\u2013579. https:\/\/doi.org\/10.1159\/000107928","journal-title":"Am J Nephrol"},{"issue":"8","key":"8491_CR29","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1111\/anae.16605","volume":"80","author":"J Lim","year":"2025","unstructured":"Lim J, Joo J, MacLean B, Richards T (2025) The use of iron after surgery: a systematic review and meta-analysis. Anaesthesia 80(8):988\u2013996. https:\/\/doi.org\/10.1111\/anae.16605","journal-title":"Anaesthesia"},{"issue":"1","key":"8491_CR30","doi-asserted-by":"publisher","first-page":"101171","DOI":"10.1016\/j.accpm.2022.101171","volume":"42","author":"M Houry","year":"2023","unstructured":"Houry M, Tohme J, Sleilaty G, Jabbour K, Bou Gebrael W, Jebara V et al (2023) Effects of ferric carboxymaltose on hemoglobin level after cardiac surgery: a randomized controlled trial. Anaesth Crit Care Pain Med 42(1):101171. https:\/\/doi.org\/10.1016\/j.accpm.2022.101171","journal-title":"Anaesth Crit Care Pain Med"},{"issue":"10369","key":"8491_CR31","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1016\/S0140-6736(22)02083-9","volume":"400","author":"PR Kalra","year":"2022","unstructured":"Kalra PR, Cleland JGF, Petrie MC, Thomson EA, Kalra PA, Squire IB et al (2022) Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial. Lancet Lond Engl 400(10369):2199\u20132209. https:\/\/doi.org\/10.1016\/S0140-6736(22)02083-9","journal-title":"Lancet Lond Engl"},{"issue":"11","key":"8491_CR32","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1056\/NEJMoa2304968","volume":"389","author":"RJ Mentz","year":"2023","unstructured":"Mentz RJ, Garg J, Rockhold FW, Butler J, De Pasquale CG, Ezekowitz JA et al (2023) Ferric carboxymaltose in heart failure with iron deficiency. N Engl J Med 389(11):975\u2013986. https:\/\/doi.org\/10.1056\/NEJMoa2304968","journal-title":"N Engl J Med"},{"issue":"25","key":"8491_CR33","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","volume":"361","author":"SD Anker","year":"2009","unstructured":"Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H et al (2009) Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 361(25):2436\u20132648. https:\/\/doi.org\/10.1056\/NEJMoa0908355","journal-title":"N Engl J Med"},{"issue":"22","key":"8491_CR34","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1001\/jama.2025.3833","volume":"333","author":"SD Anker","year":"2025","unstructured":"Anker SD, Friede T, Butler J, Talha KM, Placzek M, Diek M et al (2025) Intravenous ferric carboxymaltose in heart failure with iron deficiency: the FAIR-HF2 DZHK05 randomized clinical trial. JAMA 333(22):1965\u20131976. https:\/\/doi.org\/10.1001\/jama.2025.3833","journal-title":"JAMA"},{"issue":"10","key":"8491_CR35","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s40264-022-01216-w","volume":"45","author":"JMM Boots","year":"2022","unstructured":"Boots JMM, Quax RAM (2022) High-dose intravenous iron with either ferric carboxymaltose or ferric derisomaltose: a benefit-risk assessment. Drug Saf 45(10):1019\u20131036. https:\/\/doi.org\/10.1007\/s40264-022-01216-w","journal-title":"Drug Saf"},{"key":"8491_CR36","doi-asserted-by":"publisher","unstructured":"Schaefer B, Meindl E, Wagner S, Tilg H, Zoller H (2020) Intravenous iron supplementation therapy. Mol Aspects Med 75:100862. https:\/\/doi.org\/10.1016\/j.mam.2020.100862 (Iron in health and diseases)","DOI":"10.1016\/j.mam.2020.100862"},{"key":"8491_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010969.pub2","author":"B Mesgarpour","year":"2017","unstructured":"Mesgarpour B, Heidinger BH, Roth D, Schmitz S, Walsh CD, Herkner H (2017) Harms of off-label erythropoiesis-stimulating agents for critically ill people. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD010969.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"22","key":"8491_CR38","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1001\/jama.288.22.2827","volume":"288","author":"HL Corwin","year":"2002","unstructured":"Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Shapiro MJ et al (2002) Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA 288(22):2827\u20132835. https:\/\/doi.org\/10.1001\/jama.288.22.2827","journal-title":"JAMA"},{"key":"8491_CR39","doi-asserted-by":"publisher","first-page":"998320","DOI":"10.3389\/fneur.2022.998320","volume":"13","author":"Q Zheng","year":"2022","unstructured":"Zheng Q, Duan D, Xu J, Wang X, Ge Y, Xiong L et al (2022) Comparative safety of multiple doses of erythropoietin for the treatment of traumatic brain injury: a systematic review and network meta-analysis. Front Neurol 13:998320. https:\/\/doi.org\/10.3389\/fneur.2022.998320","journal-title":"Front Neurol"},{"issue":"9","key":"8491_CR40","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1007\/s00134-020-06175-3","volume":"46","author":"S Lasocki","year":"2020","unstructured":"Lasocki S, Kimmoun A, Chanques G, Velly L, P\u00e8ne F (2020) Treating critically ill anaemic patients with erythropoietin: why not? Intensive Care Med 46(9):1794\u20131795. https:\/\/doi.org\/10.1007\/s00134-020-06175-3","journal-title":"Intensive Care Med"},{"issue":"1\u20132","key":"8491_CR41","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1093\/milmed\/usaf289","volume":"191","author":"JD Peckham","year":"2026","unstructured":"Peckham JD, Rizzo JA, April MD, Maddry JK, Meledeo MA, Stewart IJ et al (2026) A narrative review of erythropoietin stimulating agents for trauma. Mil Med 191(1\u20132):e85\u2013e94. https:\/\/doi.org\/10.1093\/milmed\/usaf289","journal-title":"Mil Med"},{"key":"8491_CR42","doi-asserted-by":"publisher","first-page":"155052","DOI":"10.1016\/j.jcrc.2025.155052","volume":"88","author":"T Carpentier","year":"2025","unstructured":"Carpentier T, Merlin A, Cappe A, Metzelard M, Villeret L, Jeanjean P et al (2025) Erythropoietin in ICU patients receiving early red blood cell transfusions: a retrospective study of the impact on transfusion requirements. J Crit Care 88:155052. https:\/\/doi.org\/10.1016\/j.jcrc.2025.155052","journal-title":"J Crit Care"},{"issue":"9","key":"8491_CR43","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1007\/s00134-019-05686-y","volume":"45","author":"E Litton","year":"2019","unstructured":"Litton E, Latham P, Inman J, Luo J, Allan P (2019) Safety and efficacy of erythropoiesis-stimulating agents in critically ill patients admitted to the intensive care unit: a systematic review and meta-analysis. Intensive Care Med 45(9):1190\u20131199. https:\/\/doi.org\/10.1007\/s00134-019-05686-y","journal-title":"Intensive Care Med"},{"issue":"10","key":"8491_CR44","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1056\/NEJMoa071533","volume":"357","author":"HL Corwin","year":"2007","unstructured":"Corwin HL, Gettinger A, Fabian TC, May A, Pearl RG, Heard S et al (2007) Efficacy and safety of epoetin alfa in critically ill patients. N Engl J Med 357(10):965\u2013976. https:\/\/doi.org\/10.1056\/NEJMoa071533","journal-title":"N Engl J Med"},{"issue":"Pt 6","key":"8491_CR45","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1113\/jphysiol.2010.195057","volume":"589","author":"W Jelkmann","year":"2011","unstructured":"Jelkmann W (2011) Regulation of erythropoietin production. J Physiol 589(Pt 6):1251\u20131258. https:\/\/doi.org\/10.1113\/jphysiol.2010.195057","journal-title":"J Physiol"},{"issue":"2","key":"8491_CR46","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1524-4733.2005.04006.x","volume":"8","author":"R MacLaren","year":"2005","unstructured":"MacLaren R, Sullivan PW (2005) Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patients. Value Health J Int Soc Pharmacoeconomics Outcomes Res 8(2):105\u2013116. https:\/\/doi.org\/10.1111\/j.1524-4733.2005.04006.x","journal-title":"Value Health J Int Soc Pharmacoeconomics Outcomes Res"},{"issue":"3","key":"8491_CR47","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.tmrv.2020.03.003","volume":"34","author":"A Shander","year":"2020","unstructured":"Shander A, Corwin HL (2020) A narrative review on hospital-acquired anemia: keeping blood where it belongs. Transfus Med Rev 34(3):195\u2013199. https:\/\/doi.org\/10.1016\/j.tmrv.2020.03.003","journal-title":"Transfus Med Rev"},{"key":"8491_CR48","doi-asserted-by":"publisher","DOI":"10.1097\/ACO.0000000000001647","author":"A Borst","year":"2026","unstructured":"Borst A, Choorapoikayil S, Stuhlmann S, Zacharowski K, Meybohm P (2026) Advances in the understanding and management of hospital-acquired anemia. Curr Opin Anaesthesiol. https:\/\/doi.org\/10.1097\/ACO.0000000000001647","journal-title":"Curr Opin Anaesthesiol"},{"key":"8491_CR49","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s40814-020-00657-3","volume":"6","author":"J Barreda Garcia","year":"2020","unstructured":"Barreda Garcia J, Xian JZ, Pedroza C, Salahuddin M, Mak G, Keene A et al (2020) Pediatric size phlebotomy tubes and transfusions in adult critically ill patients: a pilot randomized controlled trial. Pilot Feasibility Stud 6:112. https:\/\/doi.org\/10.1186\/s40814-020-00657-3","journal-title":"Pilot Feasibility Stud"},{"issue":"19","key":"8491_CR50","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1056\/NEJM198605083141906","volume":"314","author":"BR Smoller","year":"1986","unstructured":"Smoller BR, Kruskall MS (1986) Phlebotomy for diagnostic laboratory tests in adults. N Engl J Med 314(19):1233\u20131235. https:\/\/doi.org\/10.1056\/NEJM198605083141906","journal-title":"N Engl J Med"},{"issue":"12","key":"8491_CR51","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1001\/jama.288.12.1499","volume":"288","author":"JL Vincent","year":"2002","unstructured":"Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A et al (2002) Anemia and blood transfusion in critically ill patients. JAMA 288(12):1499\u20131507. https:\/\/doi.org\/10.1001\/jama.288.12.1499","journal-title":"JAMA"},{"issue":"2","key":"8491_CR52","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3390\/jcm11020320","volume":"11","author":"P Helmer","year":"2022","unstructured":"Helmer P, Hottenrott S, Steinisch A, R\u00f6der D, Schubert J, Steigerwald U et al (2022) Avoidable blood loss in critical care and patient blood management: scoping review of diagnostic blood loss. J Clin Med 11(2):320. https:\/\/doi.org\/10.3390\/jcm11020320","journal-title":"J Clin Med"},{"issue":"1","key":"8491_CR53","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.mayocpiqo.2020.08.007","volume":"5","author":"Y Wu","year":"2021","unstructured":"Wu Y, Spaulding AC, Borkar S, Shoaei MM, Mendoza M, Grant RL et al (2021) Reducing blood loss by changing to small volume tubes for laboratory testing. Mayo Clin Proc Innov Qual Outcomes 5(1):72\u201383. https:\/\/doi.org\/10.1016\/j.mayocpiqo.2020.08.007","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"issue":"2","key":"8491_CR54","doi-asserted-by":"publisher","first-page":"e20162480","DOI":"10.1542\/peds.2016-2480","volume":"140","author":"K Steffen","year":"2017","unstructured":"Steffen K, Doctor A, Hoerr J, Gill J, Markham C, Brown SM et al (2017) Controlling phlebotomy volume diminishes PICU transfusion: implementation processes and impact. Pediatrics 140(2):e20162480. https:\/\/doi.org\/10.1542\/peds.2016-2480","journal-title":"Pediatrics"},{"issue":"19","key":"8491_CR55","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1001\/jama.2023.20820","volume":"330","author":"DM Siegal","year":"2023","unstructured":"Siegal DM, Belley-C\u00f4t\u00e9 EP, Lee SF, Hill S, D\u2019Aragon F, Zarychanski R et al (2023) Small-volume blood collection tubes to reduce transfusions in intensive care: the STRATUS randomized clinical trial. JAMA 330(19):1872\u20131881. https:\/\/doi.org\/10.1001\/jama.2023.20820","journal-title":"JAMA"},{"key":"8491_CR56","doi-asserted-by":"publisher","DOI":"10.1007\/s12630-023-02643-8","author":"V Neef","year":"2024","unstructured":"Neef V, Himmele C, Piekarski F, Blum LV, Hof L, Derwich W et al (2024) Effect of using smaller blood volume tubes and closed blood collection devices on total blood loss in patients undergoing major cardiac and vascular surgery. Can J Anaesth J Can Anesth. https:\/\/doi.org\/10.1007\/s12630-023-02643-8","journal-title":"Can J Anaesth J Can Anesth"},{"issue":"1","key":"8491_CR57","doi-asserted-by":"publisher","first-page":"e0243782","DOI":"10.1371\/journal.pone.0243782","volume":"16","author":"T Bodley","year":"2021","unstructured":"Bodley T, Chan M, Levi O, Clarfield L, Yip D, Smith O et al (2021) Patient harm associated with serial phlebotomy and blood waste in the intensive care unit: a retrospective cohort study. PLoS ONE 16(1):e0243782. https:\/\/doi.org\/10.1371\/journal.pone.0243782","journal-title":"PLoS ONE"},{"issue":"2","key":"8491_CR58","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.enfie.2023.05.001","volume":"35","author":"M Raurell-Torred\u00e0","year":"2024","unstructured":"Raurell-Torred\u00e0 M, Arias-Rivera S, Rodr\u00edguez-Delgado ME, Campos-Asensio C, Fern\u00e1ndez-Castillo RJ (2024) Effectiveness of closed blood sampling systems in intensive care patients: a scoping review. Enferm Intensiva 35(2):133\u2013145. https:\/\/doi.org\/10.1016\/j.enfie.2023.05.001","journal-title":"Enferm Intensiva"},{"key":"8491_CR59","doi-asserted-by":"publisher","first-page":"103364","DOI":"10.1016\/j.iccn.2022.103364","volume":"75","author":"S Keogh","year":"2023","unstructured":"Keogh S, Dhanani J, Levido A, Gracie C, Ilushin V, Palmer J et al (2023) Evaluation of a closed loop-blood sampling system in intensive care: a pilot randomised controlled trial. The ENCLOSE trial. Intensive Crit Care Nurs 75:103364. https:\/\/doi.org\/10.1016\/j.iccn.2022.103364","journal-title":"Intensive Crit Care Nurs"},{"issue":"10","key":"8491_CR60","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/aas.14497","volume":"68","author":"J Callum","year":"2024","unstructured":"Callum J, Putowski Z, Alhazzani W, Belley-Cote E, M\u00f8ller MH, Curry N et al (2024) Small-volume blood sample collection tubes in adult intensive care units: a rapid practice guideline. Acta Anaesthesiol Scand 68(10):1319\u20131326. https:\/\/doi.org\/10.1111\/aas.14497","journal-title":"Acta Anaesthesiol Scand"},{"issue":"3","key":"8491_CR61","doi-asserted-by":"publisher","first-page":"e252353","DOI":"10.1001\/jamanetworkopen.2025.2353","volume":"8","author":"MA Warner","year":"2025","unstructured":"Warner MA, Johnson ML, Hanson AC, Fortune E, Flaby GW, Schulte PJ et al (2025) Practical anemia bundle and hemoglobin recovery in critical illness: a randomized clinical trial. JAMA Netw Open 8(3):e252353. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.2353","journal-title":"JAMA Netw Open"},{"issue":"19","key":"8491_CR62","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1001\/jama.2023.20737","volume":"330","author":"SJ Raasveld","year":"2023","unstructured":"Raasveld SJ, de Bruin S, Reuland MC, van den Oord C, Schenk J, Aubron C et al (2023) Red blood cell transfusion in the intensive care unit. JAMA 330(19):1852\u20131861. https:\/\/doi.org\/10.1001\/jama.2023.20737","journal-title":"JAMA"},{"issue":"4","key":"8491_CR63","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00134-019-05884-8","volume":"46","author":"AP Vlaar","year":"2020","unstructured":"Vlaar AP, Oczkowski S, de Bruin S, Wijnberge M, Antonelli M, Aubron C et al (2020) Transfusion strategies in non-bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine. Intensive Care Med 46(4):673\u2013696. https:\/\/doi.org\/10.1007\/s00134-019-05884-8","journal-title":"Intensive Care Med"},{"issue":"26","key":"8491_CR64","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1056\/NEJMoa2307983","volume":"389","author":"JL Carson","year":"2023","unstructured":"Carson JL, Brooks MM, H\u00e9bert PC, Goodman SG, Bertolet M, Glynn SA et al (2023) Restrictive or liberal transfusion strategy in myocardial infarction and anemia. N Engl J Med 389(26):2446\u20132456. https:\/\/doi.org\/10.1056\/NEJMoa2307983","journal-title":"N Engl J Med"},{"issue":"11","key":"8491_CR65","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJMoa1403612","volume":"372","author":"GJ Murphy","year":"2015","unstructured":"Murphy GJ, Pike K, Rogers CA, Wordsworth S, Stokes EA, Angelini GD et al (2015) Liberal or restrictive transfusion after cardiac surgery. N Engl J Med 372(11):997\u20131008. https:\/\/doi.org\/10.1056\/NEJMoa1403612","journal-title":"N Engl J Med"},{"issue":"13","key":"8491_CR66","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1056\/NEJMoa1808561","volume":"379","author":"CD Mazer","year":"2018","unstructured":"Mazer CD, Whitlock RP, Fergusson DA, Belley-Cote E, Connolly K, Khanykin B et al (2018) Six-month outcomes after restrictive or liberal transfusion for cardiac surgery. N Engl J Med 379(13):1224\u20131233. https:\/\/doi.org\/10.1056\/NEJMoa1808561","journal-title":"N Engl J Med"},{"issue":"22","key":"8491_CR67","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1056\/NEJMoa1711818","volume":"377","author":"CD Mazer","year":"2017","unstructured":"Mazer CD, Whitlock RP, Fergusson DA, Hall J, Belley-Cote E, Connolly K et al (2017) Restrictive or liberal red-cell transfusion for cardiac surgery. N Engl J Med 377(22):2133\u20132144. https:\/\/doi.org\/10.1056\/NEJMoa1711818","journal-title":"N Engl J Med"},{"issue":"6","key":"8491_CR68","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1056\/NEJM199902113400601","volume":"340","author":"PC H\u00e9bert","year":"1999","unstructured":"H\u00e9bert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G et al (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340(6):409\u2013417. https:\/\/doi.org\/10.1056\/NEJM199902113400601","journal-title":"N Engl J Med"},{"issue":"6","key":"8491_CR69","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1001\/jama.2021.0135","volume":"325","author":"G Ducrocq","year":"2021","unstructured":"Ducrocq G, Gonzalez-Juanatey JR, Puymirat E, Lemesle G, Cachanado M, Durand-Zaleski I et al (2021) Effect of a restrictive vs liberal blood transfusion strategy on major cardiovascular events among patients with acute myocardial infarction and anemia: the REALITY randomized clinical trial. JAMA 325(6):552\u2013560. https:\/\/doi.org\/10.1001\/jama.2021.0135","journal-title":"JAMA"},{"issue":"19","key":"8491_CR70","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1001\/jama.2024.20424","volume":"332","author":"FS Taccone","year":"2024","unstructured":"Taccone FS, Rynkowski CB, M\u00f8ller K, Lormans P, Quintana-D\u00edaz M, Caricato A et al (2024) Restrictive vs liberal transfusion strategy in patients with acute brain injury: the TRAIN randomized clinical trial. JAMA 332(19):1623\u20131633. https:\/\/doi.org\/10.1001\/jama.2024.20424","journal-title":"JAMA"},{"issue":"11","key":"8491_CR71","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1056\/NEJMoa2410962","volume":"392","author":"SW English","year":"2025","unstructured":"English SW, Delaney A, Fergusson DA, Chass\u00e9 M, Turgeon AF, Lauzier F et al (2025) Liberal or restrictive transfusion strategy in aneurysmal subarachnoid hemorrhage. N Engl J Med 392(11):1079\u20131088. https:\/\/doi.org\/10.1056\/NEJMoa2410962","journal-title":"N Engl J Med"},{"issue":"8","key":"8491_CR72","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1056\/NEJMoa2404360","volume":"391","author":"AF Turgeon","year":"2024","unstructured":"Turgeon AF, Fergusson DA, Clayton L, Patton MP, Neveu X, Walsh TS et al (2024) Liberal or restrictive transfusion strategy in patients with traumatic brain injury. N Engl J Med 391(8):722\u2013735. https:\/\/doi.org\/10.1056\/NEJMoa2404360","journal-title":"N Engl J Med"},{"issue":"24","key":"8491_CR73","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1001\/jama.2025.20841","volume":"334","author":"P Kougias","year":"2025","unstructured":"Kougias P, Sharath SE, Zhan M, Carson JL, Norman LE, Mi Z et al (2025) Liberal or restrictive postoperative transfusion in patients at high cardiac risk: the TOP randomized clinical trial. JAMA 334(24):2197\u20132207. https:\/\/doi.org\/10.1001\/jama.2025.20841","journal-title":"JAMA"},{"issue":"11","key":"8491_CR74","doi-asserted-by":"publisher","first-page":"e2442361","DOI":"10.1001\/jamanetworkopen.2024.42361","volume":"7","author":"FM Carrier","year":"2024","unstructured":"Carrier FM, Cooper HA, Portela GT, Bertolet M, Lemesle G, Prochaska M et al (2024) Anemia acuity effect on transfusion strategies in acute myocardial infarction. JAMA Netw Open 7(11):e2442361. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.42361","journal-title":"JAMA Netw Open"},{"issue":"23","key":"8491_CR75","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1161\/CIRCULATIONAHA.124.071208","volume":"150","author":"AP DeFilippis","year":"2024","unstructured":"DeFilippis AP, Abbott JD, Herbert BM, Bertolet MH, Chaitman BR, White HD et al (2024) Restrictive versus liberal transfusion in patients with type 1 or type 2 myocardial infarction: a prespecified analysis of the MINT trial. Circulation 150(23):1826\u20131836. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.124.071208","journal-title":"Circulation"},{"issue":"10","key":"8491_CR76","doi-asserted-by":"publisher","first-page":"CD002042","DOI":"10.1002\/14651858.CD002042.pub6","volume":"10","author":"JL Carson","year":"2025","unstructured":"Carson JL, Stanworth SJ, Dennis JA, Fergusson DA, Pagano MB, Roubinian NH et al (2025) Transfusion thresholds and other strategies for guiding red blood cell transfusion. Cochrane Database Syst Rev 10(10):CD002042. https:\/\/doi.org\/10.1002\/14651858.CD002042.pub6","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"8491_CR77","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13063-019-3200-3","volume":"20","author":"P Meybohm","year":"2019","unstructured":"Meybohm P, Lindau S, Treskatsch S, Francis R, Spies C, Velten M et al (2019) Liberal transfusion strategy to prevent mortality and anaemia-associated, ischaemic events in elderly non-cardiac surgical patients\u2014the study design of the LIBERAL-trial. Trials 20(1):101. https:\/\/doi.org\/10.1186\/s13063-019-3200-3","journal-title":"Trials"},{"issue":"3","key":"8491_CR78","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S2213-2600(22)00353-8","volume":"11","author":"G Martucci","year":"2023","unstructured":"Martucci G, Schmidt M, Agerstrand C, Tabatabai A, Tuzzolino F, Giani M et al (2023) Transfusion practice in patients receiving VV ECMO (PROTECMO): a prospective, multicentre, observational study. Lancet Respir Med 11(3):245\u2013255. https:\/\/doi.org\/10.1016\/S2213-2600(22)00353-8","journal-title":"Lancet Respir Med"},{"key":"8491_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-026-05900-6","author":"H Buscher","year":"2026","unstructured":"Buscher H, Thao LTP, Martucci G, Gratz J, Trummer G, Schmidt M et al (2026) Major haemorrhage and blood product utilisation in patients receiving VA ECMO for cardiogenic shock: a multicentre observational study (OBLEX). Crit Care. https:\/\/doi.org\/10.1186\/s13054-026-05900-6","journal-title":"Crit Care"},{"issue":"1","key":"8491_CR80","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s13054-025-05606-1","volume":"29","author":"LTP Thao","year":"2025","unstructured":"Thao LTP, Buscher H, Nguyen TL, Martucci G, Gratz J, Trummer G et al (2025) Liberal or restrictive transfusion for veno-arterial extracorporeal membrane oxygenation patients: a target trial emulation using the OBLEX study data. Crit Care 29(1):360. https:\/\/doi.org\/10.1186\/s13054-025-05606-1","journal-title":"Crit Care"},{"issue":"10","key":"8491_CR81","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1111\/aor.70001","volume":"49","author":"A Boscolo","year":"2025","unstructured":"Boscolo A, Sella N, Pettenuzzo T, Pistollato E, Zarantonello F, Gazzea S et al (2025) Thresholds for transfusion practice during ECMO support. A systematic review and network meta-analysis. Artif Organs 49(10):1501\u20131511. https:\/\/doi.org\/10.1111\/aor.70001","journal-title":"Artif Organs"},{"issue":"4","key":"8491_CR82","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/EJA.0000000000001803","volume":"40","author":"S Kietaibl","year":"2023","unstructured":"Kietaibl S, Ahmed A, Afshari A, Albaladejo P, Aldecoa C, Barauskas G et al (2023) Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care: second update 2022. Eur J Anaesthesiol 40(4):226\u2013304. https:\/\/doi.org\/10.1097\/EJA.0000000000001803","journal-title":"Eur J Anaesthesiol"},{"issue":"1","key":"8491_CR83","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13054-023-04327-7","volume":"27","author":"R Rossaint","year":"2023","unstructured":"Rossaint R, Afshari A, Bouillon B, Cerny V, Cimpoesu D, Curry N et al (2023) The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition. Crit Care Lond Engl 27(1):80. https:\/\/doi.org\/10.1186\/s13054-023-04327-7","journal-title":"Crit Care Lond Engl"},{"issue":"26","key":"8491_CR84","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1056\/NEJM199712253372602","volume":"337","author":"P Rebulla","year":"1997","unstructured":"Rebulla P, Finazzi G, Marangoni F, Avvisati G, Gugliotta L, Tognoni G et al (1997) The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell\u2019Adulto. N Engl J Med 337(26):1870\u20131875. https:\/\/doi.org\/10.1056\/NEJM199712253372602","journal-title":"N Engl J Med"},{"issue":"9850","key":"8491_CR85","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/S0140-6736(12)60689-8","volume":"380","author":"H Wandt","year":"2012","unstructured":"Wandt H, Schaefer-Eckart K, Wendelin K, Pilz B, Wilhelm M, Thalheimer M et al (2012) Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study. Lancet Lond Engl 380(9850):1309\u20131316. https:\/\/doi.org\/10.1016\/S0140-6736(12)60689-8","journal-title":"Lancet Lond Engl"},{"issue":"19","key":"8491_CR86","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1056\/NEJMoa1212772","volume":"368","author":"SJ Stanworth","year":"2013","unstructured":"Stanworth SJ, Estcourt LJ, Powter G, Kahan BC, Dyer C, Choo L et al (2013) A no-prophylaxis platelet-transfusion strategy for hematologic cancers. N Engl J Med 368(19):1771\u20131780. https:\/\/doi.org\/10.1056\/NEJMoa1212772","journal-title":"N Engl J Med"},{"issue":"7","key":"8491_CR87","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1001\/jama.2025.7529","volume":"334","author":"RA Metcalf","year":"2025","unstructured":"Metcalf RA, Nahirniak S, Guyatt G, Bathla A, White SK, Al-Riyami AZ et al (2025) Platelet transfusion: 2025 AABB and ICTMG International Clinical Practice Guidelines. JAMA 334(7):606\u2013617. https:\/\/doi.org\/10.1001\/jama.2025.7529","journal-title":"JAMA"},{"issue":"3","key":"8491_CR88","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1056\/NEJMoa1807320","volume":"380","author":"A Curley","year":"2019","unstructured":"Curley A, Stanworth SJ, Willoughby K, Fustolo-Gunnink SF, Venkatesh V, Hudson C et al (2019) Randomized trial of platelet-transfusion thresholds in neonates. N Engl J Med 380(3):242\u2013251. https:\/\/doi.org\/10.1056\/NEJMoa1807320","journal-title":"N Engl J Med"},{"issue":"10038","key":"8491_CR89","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1016\/S0140-6736(16)30392-0","volume":"387","author":"MI Baharoglu","year":"2016","unstructured":"Baharoglu MI, Cordonnier C, Salman RAS, de Gans K, Koopman MM, Brand A et al (2016) Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. Lancet 387(10038):2605\u20132613. https:\/\/doi.org\/10.1016\/S0140-6736(16)30392-0","journal-title":"Lancet"},{"issue":"21","key":"8491_CR90","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1056\/NEJMoa2214322","volume":"388","author":"FLF van Baarle","year":"2023","unstructured":"van Baarle FLF, van de Weerdt EK, van der Velden WJFM, Ruiterkamp RA, Tuinman PR, Ypma PF et al (2023) Platelet transfusion before CVC placement in patients with thrombocytopenia. N Engl J Med 388(21):1956\u20131965. https:\/\/doi.org\/10.1056\/NEJMoa2214322","journal-title":"N Engl J Med"},{"issue":"6","key":"8491_CR91","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1055\/s-0042-1757898","volume":"49","author":"JB Larsen","year":"2023","unstructured":"Larsen JB, Hvas AM, Hojbjerg JA (2023) Platelet function testing: update and future directions. Semin Thromb Hemost 49(6):600\u2013608. https:\/\/doi.org\/10.1055\/s-0042-1757898","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"8491_CR92","doi-asserted-by":"publisher","first-page":"103930","DOI":"10.1016\/j.transci.2024.103930","volume":"63","author":"P Villar","year":"2024","unstructured":"Villar P, Carre\u00f1o S, Moro S, D\u00edez Galindo I, Bernardo \u00c1, Guti\u00e9rrez L (2024) Platelet function testing: update on determinant variables and permissive windows using a platelet-count-based device. Transfus Apher Sci Off J World Apher Assoc Off J Eur Soc Haemapheresis 63(3):103930. https:\/\/doi.org\/10.1016\/j.transci.2024.103930","journal-title":"Transfus Apher Sci Off J World Apher Assoc Off J Eur Soc Haemapheresis"},{"issue":"3","key":"8491_CR93","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.chest.2025.02.029","volume":"168","author":"A Coz Yataco","year":"2025","unstructured":"Coz Yataco A, Soghier I, H\u00e9bert PC, Belley-Cote E, Disselkamp M, Flynn D et al (2025) Transfusion of fresh frozen plasma and platelets in critically ill adults: an American College of Chest Physicians Clinical Practice Guideline. Chest 168(3):661\u2013676. https:\/\/doi.org\/10.1016\/j.chest.2025.02.029","journal-title":"Chest"},{"issue":"6","key":"8491_CR94","doi-asserted-by":"publisher","first-page":"e258","DOI":"10.1016\/S2352-3026(17)30077-7","volume":"4","author":"P Innerhofer","year":"2017","unstructured":"Innerhofer P, Fries D, Mittermayr M, Innerhofer N, von Langen D, Hell T et al (2017) Reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma (RETIC): a single-centre, parallel-group, open-label, randomised trial. Lancet Haematol 4(6):e258\u2013e271. https:\/\/doi.org\/10.1016\/S2352-3026(17)30077-7","journal-title":"Lancet Haematol"},{"issue":"10","key":"8491_CR95","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1001\/archsurg.2010.216","volume":"145","author":"JL Johnson","year":"2010","unstructured":"Johnson JL, Moore EE, Kashuk JL, Banerjee A, Cothren CC, Biffl WL et al (2010) Effect of blood products transfusion on the development of postinjury multiple organ failure. Arch Surg 145(10):973\u2013977. https:\/\/doi.org\/10.1001\/archsurg.2010.216","journal-title":"Arch Surg"},{"issue":"4","key":"8491_CR96","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1093\/bja\/aeu086","volume":"113","author":"PW Collins","year":"2014","unstructured":"Collins PW, Solomon C, Sutor K, Crispin D, Hochleitner G, Rizoli S et al (2014) Theoretical modelling of fibrinogen supplementation with therapeutic plasma, cryoprecipitate, or fibrinogen concentrate. Br J Anaesth 113(4):585\u2013595. https:\/\/doi.org\/10.1093\/bja\/aeu086","journal-title":"Br J Anaesth"},{"issue":"5","key":"8491_CR97","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1213\/ANE.0000000000001730","volume":"124","author":"MA Warner","year":"2017","unstructured":"Warner MA, Chandran A, Jenkins G, Kor DJ (2017) Prophylactic plasma transfusion is not associated with decreased red blood cell requirements in critically ill patients. Anesth Analg 124(5):1636\u20131643. https:\/\/doi.org\/10.1213\/ANE.0000000000001730","journal-title":"Anesth Analg"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-026-08491-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-026-08491-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-026-08491-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T09:18:01Z","timestamp":1781515081000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-026-08491-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":97,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["8491"],"URL":"https:\/\/doi.org\/10.1007\/s00134-026-08491-6","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"13 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Department of Anaesthesiology, Intensive Care Medicine & Pain Therapy of the University Hospital Frankfurt, Goethe University received support from B. Braun Melsungen, Melsungen (Germany), CSL Behring, Hattersheim (Germany), Fresenius Kabi, Bad Homburg (Germany), and Vifor Pharma, Munich (Germany) for the implementation of Frankfurt\u2019s Patient Blood Management program. KZ has received honoraria for participation in advisory board meetings for Haemonetics, Boston (USA) and Vifor, Munich (Germany) and received speaker fees from CSL Behring, Hattersheim (Germany), Masimo, Irvine (USA), Pharmacosmos, Copenhagen (Denmark), Boston Scientific, D\u00fcsseldorf (Germany), Salus, Bruckm\u00fchl (Germany), iSEP, Nantes (France), Edwards, Munich (Germany), Hemosonics, Asni\u00e8res-sur-Seine (France) and GE Healthcare, D\u00fcsseldorf (Germany). He is the Principal Investigator of the EU-Horizon 2020 project ENVISION (Intelligent plug-and-play digital tool for real-time surveillance of COVID-19 patients and smart decision-making in Intensive Care Units) and Horizon Europe 2021 project COVend (Biomarker and AI-supported FX06 therapy to prevent progression from mild and moderate to severe stages of COVID-19). Partner for EU Horizon 2023 project EDiHTA. KZ leads as CEO the Christoph Lohfert Foundation, Hamburg (Germany) as well as the Health, Patient Safety & PBM Foundation, Bad Homburg (Germany). DMB: speaker honoraria and travel support from CSL Vifor and Astropharma. SL received consulting and speaker fee from CSL-VIFOR, MASIMO, PHARMACOSMOS and Pfizer, outside the present work. DF received lecture and advisory fees as well as grants and scientific support from Astra Zeneca, Baxter, B. Braun Melsungen AG, Cytosorb, CSL Behring, Haemonetics, IL Werfen, LFB France, Mitsubishi Pharma, and Octapharm. G.M. received restricted research grants and consultancy fees from B. Braun Melsungen AG, 4Teen4, and Adrenomed AG outside of the submitted work. APJV is funded by Zorgonderzoek Medische Wetenschappen, part of the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (the Dutch Organization for Scientific Research, Den Haag, The Netherlands; VIDI grant project 09150172010047). APJV reports having received grants and consulting fees from AM Pharma, CSL Behring, InflaRx and Edwards Lifesciences paid to the institution. SC has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}